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Background: Considering the suggested link between vitamin D insufficiency and several chronic diseases,
attention should be given to approaches for improving vitamin D status. Elderly subjects are regarded as a high-risk
group for developing an insufficient vitamin D status. Socioeconomic, dietary, lifestyle and environmental factors
are considered as influencing factors, whereupon sex differences in predictors of vitamin D status are rarely investigated.
The purpose of this study is to identify the main predictors of serum 25-hydroxyvitamin D3 [25(OH)D3] concentrations
in elderly subjects by taking into account potential sex differences.
Methods: This is a cross-sectional study in 162 independently living German elderly aged 66 to 96 years. Serum
25(OH)D3 concentrations were assessed by an electrochemiluminescence immunoassay. Multiple regression analyses
were performed to identify predictors of 25(OH)D3 concentrations stratified by sex.
Results: Median 25(OH)D3 concentration was 64 nmol/L and none of the subjects had 25(OH)D3
concentrations < 25 nmol/L. In women, intact parathyroid hormone (iPTH) (β = −0.323), % total body fat
(β = −0.208), time spent outdoors (β = 0.328), month of blood sampling (β = 0.229) and intake of vitamin D
supplements (β = 0.172) were the predominant predictors of 25(OH)D3, whereas in men, iPTH (β = −0.254),
smoking (β = −0.282), physical activity (β = 0.336) and monthly household net income (β = 0.302) predicted 25
(OH)D3 concentrations. The final regression models accounted for 30% and 32% of the variance in 25(OH)D3
concentrations in women and men, respectively.
Conclusion: The findings indicate that 25(OH)D3 concentrations are influenced by body composition, month of blood
sampling, economic factors, lifestyle, supplement intake and iPTH, but may not be associated with age, sex, dietary
factors, kidney function and presence of selected chronic diseases in community-dwelling elderly. Furthermore, our
results provide evidence for sex-specific determinants of the vitamin D status, which ought to be considered for
preventive strategies.
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Vitamin D insufficiency is a widely recognised public health
problem, especially in elderly subjects [1]. The decrease
in the circulating concentration of 25-hydroxyvitamin D
[25(OH)D] – the established biomarker of vitamin D
status – with advancing age seems to be accompanied
by a gradual rise in chronic diseases. Experimental and
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article, unless otherwise stated.deficiency is involved in the pathogenesis of many age-
related chronic diseases, including cancer [2], cardiovascu-
lar disease [3] and diabetes mellitus [4]. In consideration
of the assumed pleiotropic functions of vitamin D beyond
its well-known role in calcium homeostasis, public health
strategies to improve vitamin D status in the elderly popu-
lation are warranted. However, uniform thresholds for
classifying serum 25(OH)D concentrations into adequacy
and insufficiency are not yet established. The most
common used cut-off values to diagnose vitamin Dsee BioMed Central. This is an Open Access article distributed under the terms
(http://creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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[5] and below 75 nmol/L [6].
To establish efficient prevention measures concerning
vitamin D insufficiency and to distinguish subjects who
would benefit most from a vitamin D screening or sup-
plementation, factors that influence vitamin D status in
the elderly have to be identified. Although low sun expo-
sure and a decline in subcutaneous vitamin D synthesis
capacity are considered as main contributing factors re-
garding low 25(OH)D concentrations in the elderly [1],
these parameters explained only a small part of the
variance in vitamin D status in previous studies [7]. This
may be due to the difficulty in obtaining accurate measures
of UVB exposure [8]. Apart from a low sun exposure, an
insufficient vitamin D status has been linked to advanced
age [9,10], female sex [9-11], low vitamin D intake [11,12],
obesity [9,11-14], sedentary lifestyle [11,12,14], smoking
[9,11,13,14], use of specific medicines [15-17] and the pres-
ence of chronic diseases [9,15]. However, most previous
studies examined only a small number of potential influ-
encing factors simultaneously. Economic aspects, dietary
factors, health status and the use of medicines were rarely
considered. Furthermore, although there is some evidence
that the predictors of serum 25(OH)D concentrations dif-
fer by sex [7,11,13,18], sex-specific analyses are especially
scarce for the elderly population. Therefore, the purpose
of the present study is to identify determinants of the
serum 25-hydroxyvitamin D3 [25(OH)D3] concentrations
in independently living elderly subjects by taking into ac-
count socioeconomic, dietary, lifestyle and health aspects
in addition to factors, such as age, month of blood sam-
pling, body composition, kidney function and concentra-
tions of intact parathyroid hormone (iPTH).
Methods
Ethics statement
This study was conducted according to the guidelines
laid down in the Declaration of Helsinki and the research
protocol was approved by the Ethical Committee of the
Faculty of Medicine at the Justus-Liebig-University of
Giessen, Germany. All participants provided written infor-
med consent before examinations.
Study design and subjects
The present investigation based on the follow-up in
2008 of the longitudinal study on nutrition and health
status of senior citizens in Giessen (GISELA study),
Germany located at northern latitude of 50.6°, in which
275 subjects participated. Investigations of the GISELA
study took place at annual intervals since 1994 and at
biannual intervals since 1998. Study participants were
volunteers and recruited by physicians, notices, senior
citizens’ meetings, advertisements in local newspapers and
through subjects who were already participants. Inclusioncriteria for enrolment in the study were an age of at least
60 years and physical mobility. Investigations have taken
place in the Institute of Nutritional Science in Giessen
from July to October.
Subjects with incomplete data on biochemical parame-
ters, body composition, lifestyle factors, including time
spent outdoors, physical activity and smoking, dietary
assessment, household net income and chronic kidney
disease were excluded (n = 105) as well as subjects who
suffered from chronic kidney disease (n = 5). Three further
subjects were excluded to minimise potential influence by
outlying 25(OH)D3 values and to obtain normal distribu-
tion of residuals. The final study sample consisted of 113
women and 49 men.
Biochemical analyses
Fasting blood samples were collected in 2008 from July
to September, and serum aliquots were stored at −70°C
until further analyses. Serum 25(OH)D3 and iPTH were
measured by an electrochemiluminescence immunoassay
(Roche Diagnostics GmbH, Mannheim, Germany) in the
Limbach Laboratory, Heidelberg, Germany. The lower
limits of quantification were 10.0 nmol/L for 25(OH)D3
and 0.127 pmol/L for iPTH, respectively [19,20]. The co-
efficients of variation for the total analytic precision of
the assays were ≤ 9.9% for 25(OH)D3 and ≤ 5.9% for
iPTH, respectively [19,20]. The laboratory performing
the 25(OH)D3 analyses took part in the Vitamin D Exter-
nal Quality Assessment Scheme. The 25(OH)D3 assay has
been standardised against liquid chromatography-tandem
mass spectrometry (LC-MS/MS) [19].
Serum 25(OH)D3 concentrations below 25.0 nmol/L
and between 25.0 and 49.9 nmol/L were considered as
deficient and insufficient vitamin D status, respectively.
Due to the ongoing discussion about optimal 25(OH)D3
values, two cut-off values were used to diagnose vitamin
D sufficiency: ≥ 50 nmol/L according to the Institute of
Medicine [5] and ≥ 75 nmol/L according to the Endocrine
Society [6].
Serum creatinine was determined by photometric detec-
tion using the Jaffé reaction (Shimadzu UV-160A) [21].
The estimated glomerular filtration rate (eGFR) was calcu-
lated as an indicator of kidney function using the simpli-
fied Modification of Diet in Renal Disease study (MDRD)
formula: eGFR (mL/min/1.73 m2) = 186 × (serum creatinine
mg/dL)–1.154 × (age)–0.203 × 0.742 (if female) [22].
Anthropometric data and body composition
Weight and height were assessed in a standardised way
with subjects in light clothing without shoes, using a
calibrated scale with an integrated stadiometer, and body
mass index (BMI) (kg/m2) was calculated. Percentage
total body fat (% TBF) was determined by a single-
frequency (50 kHz) bioelectrical impedance analyser
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and the formula of Roubenoff et al. [23].
Data on socioeconomic and lifestyle factors
Participants were asked to complete a self-administered
questionnaire on health, socioeconomic and lifestyle char-
acteristics, such as monthly household net income, smok-
ing status, physical activity, time spent outdoors, intake of
medicines and disease history (including for instance
hypertension, cardiac disease, dyslipidaemia, diabetes mel-
litus, osteoporosis, cancer, liver/gall bladder disease and
disease of the urinary tract/kidney).
Study participants were asked to record their current
time spent on different physical activities in hours per
week. The energy expenditure for the respective physical
activities was calculated by multipliers for resting metabolic
rate (RMR) according to the World Health Organization
(WHO) [24]. RMR was measured by an open-circuit indir-
ect calorimeter (Deltatrac™ MBM-100, Hoyer, Bremen,
Germany) using the equation of Weir [25]. Total energy
expenditure was calculated by the sum of the energy ex-
penditure for the respective physical activities. The physical
activity level (PAL) of each participant was computed by
dividing the total energy expenditure by the RMR [26].
Sunlight exposure was indirectly assessed by the follow-
ing question: “Please estimate, how much time do you
currently spend outdoors in minutes per day?”. In the
follow-up in 2008, blood samples of the GISELA subjects
were obtained from July to September. Mean monthly UV
indices assessed by a weather station located in the area of
Giessen (city: Langen, latitude of 50°N) ranged in 2008
from six in June (data for July were not available) to five in
August to three in September [27]. Because in 2008
the follow-up started on July the 29th, the examination
months July (n = 18) and August (n = 84) were combined
for the present analysis.
Dietary assessment
Dietary intake of vitamin D, calcium, phosphorus and
alcohol was determined using a three-day estimated diet-
ary record consisting of 146 food items and beverages,
which was developed and validated for the GISELA study
[28]. Data on vitamin D and calcium supplement intake
were collected via a self-administered questionnaire.
Statistical analyses
Continuous data are expressed as median and 5th and
95th percentiles due to the presence of non-normally
distributed variables. Descriptive characteristics were com-
pared between groups via Mann-Whitney U test for con-
tinuous variables. Chi-square test or Fisher’s exact test
was used to assess differences in proportions.
At first, we analysed whether self-reported lifetime
histories of selected diseases and/or current medicationinfluenced 25(OH)D3 concentrations by using Mann-
Whitney U test and simple and stepwise multiple linear
regression analyses adjusting for sex, age, iPTH, % TBF,
month of blood sampling, nutrient intake and lifestyle
factors, respectively. Diseases or medication which showed
associations with 25(OH)D3 concentrations were consid-
ered in subsequent multiple regression analyses.
Multiple regression analysis with backward elimination
was used to investigate the relationships between serum
25(OH)D3 as continuous outcome variable and age, sex,
body composition, eGFR, iPTH, month of blood sampling,
nutrient intake, lifestyle factors, household net income
and, if appropriate, disease histories and/or current medi-
cation as possible independent variables. Variables with a
P-value ≤ 0.100 were allowed to remain in the model. Vari-
ance inflation factors were ≤ 3 and tolerance statistics
were > 0.3, indicating that there was no multicollinearity
between parameters. To evaluate whether sex was an
effect modifier as regards the assumed associations of
lifestyle variables, iPTH, eGFR, body composition and in-
come with 25(OH)D3, interaction terms (sex × time spent
outdoors, sex × PAL, sex × smoking, sex × iPTH, sex ×
eGFR, sex × % TBF and sex × household net income) were
investigated. In the multiple regression analyses stratified
by sex, only factors which have been proved as determi-
nants of the 25(OH)D3 concentration in the combined
study population or factors for which an interaction by
sex was observed were considered as independent vari-
ables. Finally, we performed a sensitivity analysis by ex-
cluding subjects with an eGFR ≤ 30 mL/min/1.73 m2
(n = 3). Statistical analyses were conducted with SPSS®
22.0 for Windows (IBM®, Chicago, USA). Significance
level was set at P < 0.05, and all tests were two-tailed.
Results
Characteristics of the study subjects
Descriptive characteristics of the subjects are presented in
Table 1. Median 25(OH)D3 concentration was 64 nmol/L
(range: 30 – 98 nmol/L). None of the subjects had a severe
vitamin D deficiency (25(OH)D3 < 25 nmol/L). Insufficient
25(OH)D3 concentrations (< 50 nmol/L) were found in
21.2% of the females and 14.3% of the males (19.1%
combined) and concentrations ≥ 75 nmol/L were evident
in 19.5% of the females and 18.4% of the males (19.1%
combined). With regard to these results, no sex differ-
ences were found.
Median vitamin D status and 5th and 95th percentiles
according to characteristics of the study population are
shown in Table 2. Lower 25(OH)D3 concentrations were
observed in overweight/obese subjects, subjects with hy-
perparathyroidism as well as subjects with a household
net income < 1500 € per month. In addition, current/ex-
smokers and subjects aged 76 and older showed a trend
towards lower 25(OH)D3 concentrations.
Table 1 Descriptive characteristics of the study populationa)
Women (n = 113) Men (n = 49)
P b)Median P5, P95 Median P5, P95
25-Hydroxyvitamin D3 [nmol/L]
c) 62.5 39.0 – 87.6 65.6 44.9 – 88.1 0.251
Age (years) 75.0 68.7 – 85.6 76.0 67.5 – 85.0 0.196
Body mass index (kg/m2) 27.1 21.1 – 35.0 26.4 21.7 – 33.9 0.792
Total body fat (%) 42.7 32.1 – 50.6 30.9 21.7 – 43.3 < 0.001
Glomerular filtration rate (mL/min/1.73 m2) 55.7 39.4 – 69.1 61.5 41.3 – 79.9 < 0.001
Intact parathyroid hormone [pmol/L] 4.6 2.6 – 12.1 4.4 2.1 – 10.6 0.717
Blood sampling in September (n, %) 43 38.1 17 34.7 0.726
Time spent outdoors (min/d) 120 37 – 360 150 30 – 540 0.033
Dietary vitamin D intake (μg/d) 3.0 0.4 – 10.3 5.1 0.8 – 19.6 0.099
Vitamin D supplement users (n, %) 14 12.4 3 6.1 0.278
Dietary calcium intake (g/d) 1.0 0.5 – 1.7 1.0 0.5 – 1.6 0.969
Calcium supplement users (n, %) 41 36.3 9 18.4 0.027
Dietary phosphorus intake (g/d) 1.2 0.8 – 2.1 1.4 1.0 – 2.5 0.006
Alcohol intake (g/d) 0.5 0.0 – 21.7 5.3 0.0 – 28.5 0.010
Physical activity level 1.7 1.5 – 2.0 1.6 1.5 – 1.9 0.066
Current or ex-smokers (n, %) 29 25.7 33 67.3 < 0.001
Household income≥ 1500 €/month (n, %) 62 54.9 39 79.6 0.004
Osteoporosis diagnosis/current medication (n, %) 48 42.5 4 8.2 < 0.001
a)Data are presented as median, 5th and 95th percentiles for continuous variables and absolute and relative frequencies for categorical variables.
b)Mann-Whitney U test, Chi-square test and Fischer’s exact test for analysing sex differences.
c)To convert nmol/L in μg/L, divide by 2.496.
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serum 25-hydroxyvitamin D3 concentrations
Subjects with and without a reported lifetime diagnosis
of selected diseases (hypertension, cardiac disease, dys-
lipidaemia, diabetes mellitus, osteoporosis, cancer, liver/
gall bladder disease and urinary tract/kidney disease)
and/or current medication for such diseases did not sig-
nificantly differ in their 25(OH)D3 concentrations (data
not shown). In linear regression analyses, neither self-
reported disease histories nor related medication were
significantly associated with 25(OH)D3 concentrations
before and after adjusting for sex, age, iPTH, % TBF,
month of blood sampling, time spent outdoors, PAL,
vitamin D intake, use of vitamin D supplements, calcium
intake, alcohol consumption and smoking (data not
shown), except for intake of osteoporosis drugs, which
was associated with higher 25(OH)D3 concentrations
before (β = 0.159; P = 0.043), but not after multiple ad-
justments (β = 0.125; P = 0.069). Intake of hormones and
corticoids showed no associations with 25(OH)D3 con-
centrations before and after adjustments, respectively
(data not shown). Therefore, only the variable ‘lifetime
history of osteoporosis and/or current osteoporosis medi-
cation’ was considered as a potential determinant of the
25(OH)D3 concentration in the subsequent multiple re-
gression analyses.Independent determinants of 25-hydroxyvitamin D3 in
the combined study population and stratified by sex
Table 3 shows the results of the multiple regression ana-
lyses with the 25(OH)D3 concentration as the dependent
variable. In the pooled analysis of women and men com-
bined, iPTH, % TBF and smoking were independent
negative determinants of the 25(OH)D3 concentration,
whereas time spent outdoors, blood sampling in September,
PAL and intake of vitamin D supplements were significant
positive determinants. When iPTH was omitted from the
analysis, the results in view of the other predictor variables
remained almost unchanged (data not shown). Except for
intake of vitamin D supplements, which showed a border-
line significant association with 25(OH)D3 concentrations
(P = 0.06), and the adjusted coefficient of determination
(R2) of the final regression model was reduced to 0.204.
When interaction terms were added separately to the
regression model, effect modification by sex was observed
with regard to the association of smoking behaviour and
income with 25(OH)D3, respectively (all P < 0.05).
In subsequent sex-specific multiple regression analyses
(Table 3), those variables which were identified as deter-
minants in the combined population as well as factors
for which an interaction by sex was observed were consid-
ered as independent variables, i.e. iPTH, % TBF, time spent
outdoors, month of blood sampling, smoking behaviour,
Table 3 Independent predictors of 25(OH)D3 concentrations in the combined population and in women and men
separatelya)
Combined sexes (n = 162)b) Women (n = 113)c) Men (n = 49)c),d)
25(OH)D3 [nmol/L] 25(OH)D3 [nmol/L] 25(OH)D3 [nmol/L]
B β P B β P B β P
Intercept 50.547 < 0.0001 84.061 < 0.0001 9.646 0.654
Intact parathyroid hormone [pmol/L] −1.324 −0.286 < 0.0001 −1.558 −0.323 0.0001 −1.041 −0.254 0.043
Total body fat (%) −0.398 −0.224 0.002 −0.549 −0.208 0.013
Smoking (no/yes) −4.291 −0.151 0.030 −7.501 −0.282 0.026
Time spent outdoors (min/d) 0.027 0.242 0.001 0.041 0.328 0.0002
Month of blood sampling (July/August vs. September) 5.946 0.208 0.003 6.731 0.229 0.007
Physical activity level 17.489 0.189 0.008 35.623 0.336 0.011
Vitamin D supplements (no/yes) 6.782 0.151 0.028 7.454 0.172 0.040
Household income≥ 1500 €/month (no/yes) 9.362 0.302 0.020
Adjusted R2 for the final model 0.280 0.296 0.316
Abbreviations: 25(OH)D3, 25-hydroxyvitamin D3; adjusted R
2, proportion of the total variance explained by the final model.
a)Multiple linear regression analyses were performed using stepwise backward procedure and the 25(OH)D3 concentration as the dependent variable. The results
of the analyses are expressed in terms of the non-standardised coefficient beta (B), standardised coefficient beta (β) and the adjusted coefficient of determination
(R2) for the final model. Only variables, which remained in the final model, are presented.
b)Serum 25(OH)D3 concentration as dependent variable and age, sex, total body fat, estimated glomerular filtration rate, intact parathyroid hormone, month of
blood sampling, time spent outdoors, intake of dietary vitamin D, vitamin D supplements, dietary calcium, calcium supplements, phosphorus and alcohol, physical
activity level, smoking and household net income as possible independent variables.
c)Serum 25(OH)D3 concentration as dependent variable and total body fat, intact parathyroid hormone, month of blood sampling, time spent outdoors, intake of
vitamin D supplements, physical activity level, smoking and household net income as possible independent variables.
d)When only intact parathyroid hormone, physical activity level, smoking and household net income were included in the male regression model, the results
remained unchanged.
Table 2 Vitamin D status according to selected characteristics of the study populationa)
25-Hydroxyvitamin D3 [nmol/L]
P b)Median P5, P95
Age < 76 years (n = 82) 65.6 33.8 – 89.9
0.109
Age ≥ 76 years (n = 80) 61.2 43.1 – 79.2
Body mass index < 25 kg/m2 (n = 51) 67.3 45.0 – 89.4
0.015
Body mass index ≥ 25 kg/m2 (n = 111) 60.7 38.5 – 84.3
Blood sampling in July/August (n = 102) 61.6 38.0 – 84.1
0.280
Blood sampling in September (n = 60) 66.0 44.5 – 90.0
Vitamin D supplement non users (n = 145) 62.9 39.7 – 87.2
0.239
Vitamin D supplement users (n = 17) 67.4 32.8 – .
Intact parathyroid hormone ≤ 6.9 pmol/L (n = 138) 64.2 45.3 – 88.5
0.001
Intact parathyroid hormone > 6.9 pmol/Lc) (n = 24) 51.7 30.3 – 78.2
eGFR < 60 mL/min/1.73 m2 (n = 99) 61.4 39.6 – 87.3
0.297
eGFR ≥ 60 mL/min/1.73 m2 (n = 63) 65.6 39.2 – 88.2
Never-smokers (n = 100) 64.0 39.6 – 88.8
0.162
Current or ex-smokers (n = 62) 61.7 39.3 – 86.6
Household income < 1500 €/month (n = 61) 56.9 39.6 – 84.3
0.038
Household income ≥ 1500 €/month (n = 101) 65.6 39.4 – 90.0
Osteoporosis diagnosis/current medication (n = 52) 64.3 39.9 – 91.7
0.346
No osteoporosis diagnosis/current medication (n = 110) 62.2 38.5 – 85.0
Abbreviations: eGFR, estimated glomerular filtration rate.
a)Data are presented as median, 5th and 95th percentiles.
b)Mann-Whitney U test for analysing group differences.
c)Intact parathyroid hormone concentrations > 6.9 pmol/L indicate hyperparathyroidism.
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income. In women, iPTH and % TBF were independent
negative determinants of the 25(OH)D3 concentration,
whereas time spent outdoors, blood sampling in September
and intake of vitamin D supplements were identified as
positive determinants. In men, iPTH and current or past
smoking were negative predictors of the 25(OH)D3 con-
centration, whereas PAL and a monthly household net
income ≥ 1500 € were positive determinants. The respect-
ive regression models accounted for 28%, 30% and
32% of the variance in 25(OH)D3 concentrations in the
combined study population, in women and in men, re-
spectively. However, iPTH was no significant predictor
in men after excluding one male subject with an iPTH
value of 21 pmol/L.
The results of the multiple regression analyses (Table 3)
remained unchanged when lifetime diagnosis of osteo-
porosis/current osteoporosis medication was considered
as a covariate. When analyses were repeated by using
the square root transformed 25(OH)D3 concentrations,
the results regarding the independent predictors of 25
(OH)D3 were almost identical (data not shown), but the
regression models explained slightly higher proportions
of the variance in 25(OH)D3 in the combined study
population (R2 = 0.285) and in women (R2 = 0.304), but
not in men (R2 = 0.313).
Finally, we performed a sensitivity analysis excluding
subjects with an eGFR ≤ 30 mL/min/1.73 m2 (n = 3). By
doing this, the results with regard to the determinants
of the 25(OH)D3 concentration remained essentially un-
changed (data not shown).
Discussion
The findings of the present study indicate that serum 25
(OH)D3 concentrations are influenced by body compos-
ition, month of blood sampling, socioeconomic factors,
lifestyle variables, and iPTH, but may not be associated
with sex, age, eGFR, dietary intake of vitamin D, calcium,
phosphorus and alcohol, and selected disease histories or
medication in community-dwelling elderly subjects.
Although vitamin D status did not significantly differ
between sexes, our results provide evidence for sex-
specific determinants of the 25(OH)D3 concentration.
In women, iPTH, body composition, sun exposure
(reflected by month of blood sampling and time spent
outdoors) and intake of vitamin D supplements were
the predominant predictors, whereas in men, iPTH,
smoking, PAL and household net income predicted 25
(OH)D3 concentrations. However, the impact of iPTH
on 25(OH)D3 in men relied on the inclusion of one sub-
ject with a particularly high iPTH value. Findings from
previous studies also point to sex differences in predictors
of 25(OH)D concentrations [7,11,18], but in these stud-
ies, categorised variables were primarily investigated andinteraction terms were not specifically addressed. In ad-
dition, BMI and not % TBF was considered as potential
determinant, which might be critical considering that
women exhibited a higher % TBF for a given BMI than
men [29] and that the % TBF has been proven as a
stronger determinant of 25(OH)D3 than anthropometric
variables [13].
In contrast to some previous studies in elderly Europeans
[30-32], no participant of the GISELA study had a severe
vitamin D deficiency and only 19% showed 25(OH)D3
concentrations below 50 nmol/L. This may be partially
due to the fact that our study is restricted to the summer
months and that our subjects were above-average edu-
cated and health-conscious volunteers. There is evidence
that the assessment of the 25(OH)D concentration by
immunoassays may result in an overestimation of the
prevalence of vitamin D deficiency when standardisation
against LC-MS/MS is missing [31]; however, the 25(OH)
D3 assay used in the present study has been standardised
against LC-MS/MS. The prevalence of vitamin D insuffi-
ciency increased to 81% when applying the higher cut-off
value of 75 nmol/L. Therefore, the classification and,
consequently, the interpretation may depend on both the
respective assay and the cut-off value used.
Serum iPTH was one of the strongest negative pre-
dictors of 25(OH)D3 in our study population. The inverse
relationship between iPTH and 25(OH)D has been fre-
quently reported in the literature [30,33], and may func-
tion in both directions: Low 25(OH)D3 concentrations
may result in low serum calcium concentrations followed
by a stimulation of iPTH secretion, which in turn
promotes the production of 1,25-dihydroxyvitamin D3
[1,25(OH)2D3] and consequently increases the turnover of
25(OH)D3 [34,35].
In agreement with previous findings [9,11-14,36], our
results demonstrate that compared with lean subjects,
overweight and obese individuals have significantly lower
25(OH)D3 concentrations. However, there is still a debate
on the underlying mechanism as regards this association.
Several theories have been proposed. The most popular
are: 1) sequestration of vitamin D by fat cells [37]; 2) volu-
metric dilution effect [36]; 3) sedentary lifestyle [38]; and
finally, 4) reverse causality [39]. In the present study, the
inverse association between % TBF and 25(OH)D3 was
independent of lifestyle factors and predominantly found
in women, possibly due to the higher amount of TBF in
women than in men [13].
With regard to lifestyle factors, we found associations
of time spent outdoors, PAL and smoking with 25(OH)
D3 regardless of body composition. In this context, sex
may act as an effect modifier. The time spent outdoors
seems to have an effect on 25(OH)D3 predominantly in
women, whereas physical activity and smoking predicted
25(OH)D3 in men. According to the results of previous
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gardening, are associated with a lower likelihood of an
inadequate vitamin D status in elderly people [32,40].
We did not distinguish physical activities by type or
location, so the observed sex differences in our study
may be attributed to sex-specific physical activity pattern
and differences in the intensity, time of day and clothing
while engaged in activities. For example, female subjects
of the GISELA study spent more time on household
chore than men (Median: 120 vs. 34 min/d; P < 0.001),
whereas men spent significantly more daily time on gar-
dening than women (Median: 43 vs. 17 min/d; P < 0.05).
One may speculate that PAL reflects the UVB exposure
to some extent analogous to the reported time spent
outdoors and effects of both parameters in one regres-
sion model may cancel each other out. However, collin-
earity was not found in our study. This indicates that
independent effects might exist as in the total popula-
tion both parameters proved as independent predictors.
These findings are in line with a cross-sectional study of
644 subjects aged 60 to 84 years, in which the associ-
ation between physical activity and 25(OH)D was inde-
pendent of time spent outdoors and also only found in
men [18]. Furthermore, a prospective study over a mean
follow-up of 2.6 years in 686 community-dwelling older
adults demonstrated that higher physical activity increased
25(OH)D concentration after adjusting for sun exposure
[41]. While the positive impact of sun exposure on vita-
min D levels is well documented, the role of physical
activity and smoking is less well understood. Some studies
reported significant associations [14,42,43], but especially
the association between smoking and 25(OH)D was fre-
quently not found in other studies [7,10,18]. The smaller
proportion of female smokers in the present study may
have caused the missing impact of smoking on 25(OH)D3
concentrations in women. Apart from the suggested indir-
ect effects of physical activity on vitamin D through sun
exposure and changes in body composition [7,40], phys-
ical activity may directly influence vitamin D by changes
in calciotropic hormones or by increasing concentrations
of insulin-like growth factor-I [32,44,45]. Whether smok-
ing has a direct effect on the vitamin D metabolism is
unclear. There is some evidence that smoking may affect
the synthesis of 25(OH)D by inhibiting the expression of
cytochrome P450 2R1 in the liver [46]. In addition, benzo
[a]pyrene, which is produced by cigarette combustion,
may exaggerate the degradation of 25(OH)D3 and 1,25
(OH)2D3 by stimulating the 1,25(OH)2D3-dependent in-
duction of cytochrome P450 24A1 [47].
Economic aspects affected the vitamin D status in our
subjects, inasmuch as we found an association between
household income and 25(OH)D3 concentrations in men.
Women showed no significant association, possibly
because they generally reported lower incomes. Someprevious studies also indicated a positive influence of
a high income on 25(OH)D3 [48], whereas others could
not confirm an association [38,43]. As the classification of
income and the population characteristics vary widely
between studies, direct comparisons of study results are
difficult. The majority of previous studies as well as our
study did not analyse individual but household income,
what may bias the association. It can be assumed that the
household income might partially reflect the marital status
of subjects.
Dietary factors, such as intake of vitamin D, calcium,
phosphorus and alcohol did not affect 25(OH)D3 concen-
trations in our study cohort. In contrast, several previous
studies have confirmed vitamin D intake as an independ-
ent predictor of 25(OH)D concentrations [11,12,15]. The
missing association between vitamin D intake and 25(OH)
D3 concentrations in our study may be due to the facts
that we distinguished between dietary and supplemental
vitamin D and food fortification is not as much common
in Germany as in the US and Canada. Other European
studies also found no significant association between diet-
ary vitamin D and 25(OH)D [14,31]. Furthermore, our
study was restricted to the summer, when the effect of the
low habitual vitamin D intake may be masked by the con-
tribution of daily sun exposure to 25(OH)D3 concentra-
tions. However, the use of vitamin D supplements resulted
in higher 25(OH)D3 concentrations of about 7 nmol/L,
despite the small proportion of subjects who took vitamin
D supplements. The effect was predominant in women,
most likely because only three male subjects reported an
intake of vitamin D supplements. With the exception of
one male subject, all vitamin D supplement users also
consumed calcium supplements. This makes it difficult to
distinguish between the individual effects of the two sup-
plements, and could indicate a treatment of osteoporosis
[49]. In this context, we want to emphasise that lifetime
diagnosis of osteoporosis as well as the other investigated
chronic diseases along with current medication showed
no influence on 25(OH)D3 concentrations in our cohort.
Some researchers [42] suggested that the observed associ-
ations between chronic diseases and 25(OH)D concentra-
tions are explained by non-disease factors, such as PAL
and sun exposure, and thus do not represent causal asso-
ciations. The missing associations in our study population
may be because subjects with and without reported life-
time history of selected diseases and/or accompanying
medication did not considerably differ in lifestyle factors,
such as time spent outdoors, PAL and vitamin D intake
(data not shown). Furthermore, some diseases and medi-
cation were rarely reported by our participants, such as
diabetes and insulin or cancer and cytostatic drugs (data
not shown).
In summary, we considered a variety of potential de-
terminants of 25(OH)D3, but the final regression model
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concentrations in the combined study population. Slightly
higher percentages were observed when sex-specific ana-
lyses were performed, resulting in a R2 of 0.30 in women
and 0.32 in men. Previous studies [7,11,12,15,18,48] often
explained comparable or somewhat lower proportions
of between-subject variance in 25(OH)D concentrations.
The relatively low explanatory power may be attributed to
the indirect assessment of lifestyle factors, but may also
result from other factors, such as genetics, serum calcium
concentration and skin type. However, even in studies
with an evaluation of genetic factors and a more detailed
assessment on individual sun exposure, only 54% of the
variation in 25(OH)D concentrations were explained,
whereupon 36% and 14% were due to sun exposure re-
lated factors and genetic factors, respectively [50]. Conse-
quently, up to now, the identified predictors of 25(OH)D
cannot be considered as reliable surrogate parameters of
the individual 25(OH)D concentration [15], but may help
to identify subjects at risk for vitamin D insufficiency.
A main strength of our study is that measurements of
25(OH)D3 were performed in a single batch and standar-
dised against LC-MS/MS. Additional strengths are the
recruitment of subjects from a single geographic area
and the consideration of a variety of potential determi-
nants, including also health aspects, and the fact that
our study population, which exclusively comprised sub-
jects > 65 years, was free of a severe vitamin D deficiency.
Seasonal and diurnal variations in serum 25(OH)D3 con-
centrations were minimised by blood sampling in the
morning hours from July to September. Main limitations
of the present study lie in the cross-sectional nature, the
relatively small sample size and the fact that the GISELA
cohort is not a nationally representative sample. In view of
the sample size, the statistical power might be too low to
detect moderate associations, particularly in men. Individ-
ual serum 25(OH)D3 concentrations were only measured
once and thus, might not reflect year-long vitamin D
status. Because information on skin type, clothing habits,
sun protection practices, past vacations in sunny areas
and time of day when subjects were outside was not
assessed, precise estimation of individual UVB expos-
ition is difficult. In addition, we relied on self-reported
data concerning dietary intake, lifestyle factors, income
and health status. Finally, information on reason, type,
dosage and duration of vitamin D supplementation was
not available.
Conclusion
Elderly people living in private households can generally
achieve a vitamin D status > 50 nmol/L in the summer
months when they follow an active and health conscious
lifestyle, including outdoor activities of approximately
two hours a day, abstain from smoking and maintain anormal body weight. Thus, vitamin D status is modifi-
able throughout behavioural interventions. Although
vitamin D status did not significantly differ between
sexes, sex-specific determinants of 25(OH)D3 concentra-
tions seem to exist. While iPTH was a negative predictor
of vitamin D in both sexes, % TBF, sun exposure and
intake of supplements had a greater impact in women,
whereas smoking, PAL and monthly household net in-
come predicted 25(OH)D3 concentrations predominantly
in men. This should be considered when recommenda-
tions to improve vitamin D status are implemented.
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